Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
about
Clinical applications, limitations and future role of transient elastography in the management of liver disease.Chronic hepatitis C and liver fibrosis.Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.Non-invasive diagnosis of hepatitis B virus-related cirrhosisOverview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.Non-invasive assessment of liver fibrosis in chronic hepatitis C.Meta-analyses of FibroTest diagnostic value in chronic liver disease.Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers.Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageIs chronic hepatitis C virus infection a risk factor for breast cancer?Liver biopsy for histological assessment: The case against.Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.Non invasive assessment of liver fibrosis in chronic hemodialysis patients with viral hepatitis C.Noninvasive diagnosis of hepatic fibrosis in chronic hepatitis C.FibroMAX: towards a new universal biomarker of liver disease?Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.Assessing liver fibrosis.Assessment of liver fibrosis: noninvasive means.Management of nonresponsive hepatitis C.Non-invasive assessment of liver fibrosis: it is time for laboratory medicine.Non-invasive assessment of liver fibrosis in chronic viral hepatitis.Checkmate to liver biopsy in chronic hepatitis C?Non-invasive evaluation of liver fibrosis: a comparison of ultrasound-based transient elastography and MR elastography in patients with viral hepatitis B and C.Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.Noninvasive diagnosis of liver fibrosis: The importance of being reimbursed.Applicability and variability of liver stiffness measurements according to probe position.How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?Exceeding the limits of liver histology markers.Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers.Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
P2860
Q26768262-235A34B0-39A5-4CF2-9DC0-3D2509FE36DEQ26825671-3FEACB1E-6CDF-41C5-924D-464ABDFFDC10Q30435394-CC0AFC99-BBE7-4F09-AA7D-6AA18A8B4C12Q30442641-4FDC4C3B-6A8B-4664-8368-1DED1ED8D5C2Q30464608-472C6B3D-9936-4C72-9D2C-828AF8367B71Q30474738-171EEDC7-40BB-4D96-AA1F-AB4D3A59D4FBQ33302708-DF9FFF99-C5F0-4EB8-A315-01D385EC86B3Q33389189-A8D168FF-4E38-4F5D-9BE4-5B701C5AF99DQ33872843-FF5E4A52-0FE6-4207-870D-F841CC39EC65Q34041411-79D2529B-F1B0-4867-9F92-1DF8B40BDD78Q34469006-4BE33E29-FB99-49BA-9F57-FFDD55FB8A93Q36406176-B233B9F5-D064-4195-9C36-DC76C1732437Q36612307-FCC78D1B-00E5-4CAC-8870-51CDC79D72ADQ36914350-593B3A93-34D1-46EB-B242-084C20F001BDQ36950410-DFD815C7-17BF-4D17-B844-D4840287DD8DQ37192623-9BABFBCB-F48B-4806-A1C8-729DA109CA48Q37345958-86BD2939-F266-49E6-B1E3-9F645DF97C3FQ37536973-90DBA0B9-B7F8-4A8B-81F4-00C47A23768AQ37727164-9397A009-15E0-4F9C-B91B-E06C43B2F325Q37801658-BB9679B7-A8EF-4AF7-B31B-48436A53B498Q41278105-3B02F7F2-23A0-439E-8445-D230EDD6B9EFQ41678369-6393E1D5-3CDA-4EA1-AE5A-632F20C8DDEFQ42259889-909B278C-8103-4C48-AA6B-F6446E71317FQ42272013-94FA8778-7106-4D42-90FE-C1706E7E9BAEQ42535301-E44A2F56-A0A9-447D-9901-FC748CA3E6C6Q42547916-0ABEE2CD-FE30-4C5D-95A5-31A8D8BB7EE2Q43046834-94BAE774-1AB2-4F65-B304-71F868415463Q43185946-18AC2E03-ACDD-431E-9225-2D0F254375BFQ45149873-14C61BDB-499E-4930-A41F-0E9EACB52CF4Q45365125-C8BE0F34-FEA5-4BD6-807B-257EEC0B93B2
P2860
Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Evolving practices of non-inva ...... ance: time for new guidelines?
@en
Evolving practices of non-inva ...... ance: time for new guidelines?
@nl
type
label
Evolving practices of non-inva ...... ance: time for new guidelines?
@en
Evolving practices of non-inva ...... ance: time for new guidelines?
@nl
prefLabel
Evolving practices of non-inva ...... ance: time for new guidelines?
@en
Evolving practices of non-inva ...... ance: time for new guidelines?
@nl
P2093
P1476
Evolving practices of non-inva ...... ance: time for new guidelines?
@en
P2093
Françoise Roudot-Thoraval
Gerard Babany
Jacques Denis
Laurent Castera
P304
528-9; author reply 529-30
P356
10.1016/J.JHEP.2006.12.002
P577
2006-12-18T00:00:00Z